Biotech Values

[DewDiligence]

RVNC caveat—It’s possible that ASPEN-OLS is fully enrolled because the FDA agreed to lower the target enrollment due to COVID-19. I just realized that Mark Foley’s language on today’s CC leaves enough wiggle room for the above interpretation.